logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Jingsong Zhang

h lee moffitt cancer center
H指数:33
被引数:6,334

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A phase II study assessing the feasibility and clinical efficacy of adaptive immunotherapy combination with VEGFR-TKI in patients with advanced renal cell carcinoma

评估适应性免疫疗法联合VEGFR-TKI在晚期肾细胞癌患者中可行性与临床疗效的II期研究

Future Oncology
IF2.6
2026-09-100
PRE
Firas Hatoum; Brandon Dyer; Jazlyn Heiligh; Trey Poehlman; Jingsong Zhang; Gigi Jameel; Sarah Mizelle; Aditi Patel; Amy Schneider; Adnan Fazili; Jeffrey S. Johnson; Justin W. Miller; Gabriel Roman Souza; Nadine Mahmoud; Keerthi Gullapalli; Youngchul Kim; Philippe E. Spiess; Robert Gatenby; Alexander R.A. Anderson; Jad Chahoud
Pembrolizumab plus high-dose IL-2 in advanced clear cell renal cell carcinoma: six-year survival outcomes and molecular signatures from a phase 2 trial

帕博利珠单抗联合高剂量IL-2在晚期透明细胞肾细胞癌中的应用：一项2期试验的6年生存结局及分子特征

Nature Communications
IF15.7
2026-05-250
OAAI
Jeffrey S. Johnson; Justin W. Miller; Firas Hatoum; Michael J. Schell; Xiaoqing Yu; Gabriel Roman Souza; Sarah Mizelle; Keerthi Gullapalli; Adnan Fazili; Rohit Jain; Jonathan Chatzkel; Ling Cen; Jasreman Dhillon; Christopher Cubitt; Jiqiang Yao; Junmin Whiting; Jiannong Li; Jennifer Swank; Ghazal Jameel; Jingsong Zhang; Xuefeng Wang; Philippe E. Spiess; Mayer Fishman; Jad Chahoud
Phase 2 study of dostarlimab plus niraparib in stage III-IV recurrent or refractory Penile squamous cell carcinoma

II期研究： dostarlimab 联合 niraparib 治疗III期-IV期复发性或难治性阴茎鳞状细胞癌

Future Oncology
IF2.6
2025-10-300
PRE
Firas Hatoum; Gabriel Roman Souza; Jeff Johnson; Justin Miller; Adnan Fazili; Curtis Alvin Pettaway; Matthew T. Campbell; Robin Neubauer; Andrew Johns; Sarah Raymond Mizelle; Youngchul Kim; Juskaran Chadha; Jingsong Zhang; Ghazal Jameel; Erika Oschmann; Jasreman Dhillon; Anay Moscu; Ryan Janeway; Walt Harris; Xin Lu; Philippe E. Spiess; Jad Chahoud
Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial
NATURE MEDICINE
IF50
2024-11-091
PRE
Li, Roger; Villa, Nancy Y.; Yu, Xiaoqing; Johnson, Joseph O.; Borjas, Gustavo; Dhillon, Jasreman; Moran-Segura, Carlos M.; Kim, Youngchul; Francis, Natasha; Dorman, Denise; Powers, John J.; Sexton, Wade J.; Spiess, Philippe E.; Poch, Michael A.; Zemp, Logan; Gilbert, Scott M.; Zhang, Jingsong; Pow-Sang, Julio M.; Anderson, Alexander R. A.; Li, Tingyi; Wang, Xuefeng; Grass, G. Daniel; Burke, James M.; Dinney, Colin P. N.; Rodriguez, Paulo C.; Jain, Rohit K.; Mule, James J.; Conejo-Garcia, Jose R.
Three- and Seven-month Prostate-specific Antigen Levels as Prognostic Markers for Overall Survival in Metastatic Hormone- sensitive Prostate Cancer: Results from SWOG S1216, a Phase 3 Randomized Trial of Androgen Deprivation Plus Orteronel or Bicalutamide

3个月和7个月的前列腺特异性抗原水平可作为转移性激素敏感性前列腺癌总生存期的预后指标: SWOG S1216的结果，这是一项雄激素剥夺加Orteronel或比卡鲁胺的3期随机试验

EUROPEAN UROLOGY ONCOLOGY
IF9.3
2024-10-012
OA
Parikh, Mamta; Tangen, Catherine; Hussain, Maha H. A.; Gupta, Shilpa; Callis, Sam; Jo, Yeonjung; Harzstark, Andrea; Paller, Channing J.; George, Saby; Zibelman, Matthew R.; Cheng, Heather H.; Maughan, Benjamin L.; Zhang, Jingsong; Pachynski, Russell K.; Bryce, Alan H.; Lin, Daniel W.; Quinn, David I.; Lerner, Seth P.; Thompson, Ian M.; Dorff, Tanya B.; Lara, Primo N.; Agarwal, Neeraj
Markers of bone metabolism and overall survival in men with bone-metastatic hormone sensitive prostate cancer (HSPC): A subset analysis of SWOG S1216, a phase III trial of androgen deprivation with or without orteronel
PROSTATE CANCER AND PROSTATIC DISEASES
IF5.8
2024-02-290
PRE
Lara Jr, Primo N.; Mayerson, Edward; Gertz, Erik; Tangen, Catherine; Goldkorn, Amir; van Loan, Marta; Hussain, Maha; Gupta, Shilpa; Zhang, Jingsong; Parikh, Mamta; Twardowski, Przemyslaw; Quinn, David I.; LeBlanc, Michael; Thompson, Ian; Agarwal, Neeraj
Bone Biomarkers and Subsequent Survival in Men with Hormone-sensitive Prostate Cancer: Results from the SWOG S1216 Phase 3 Trial of Androgen Deprivation Therapy with or Without Orteronel
EUROPEAN UROLOGY
IF25.2
2024-02-016
OA
Lara, Primo N.; Mayerson, Edward; Gertz, Erik; Tangen, Catherine; Goldkorn, Amir; van Loan, Marta; Hussain, Maha; Gupta, Shilpa; Zhang, Jingsong; Parikh, Mamta; Twardowski, Przemyslaw; Quinn, David I.; Leblanc, Michael; Vogelzang, Nicholas J.; Thompson, Ian; Agarwal, Neeraj
Rucaparib for the Treatment of Metastatic Castration-resistant Prostate Cancer Associated with a DNA Damage Repair Gene Alteration: Final Results from the Phase 2 TRITON2 Study
EUROPEAN UROLOGY
IF25.2
2023-09-0127
OA
Abida, Wassim; Campbell, David; Patnaik, Akash; Bryce, Alan H.; Shapiro, Jeremy; Bambury, Richard M.; Zhang, Jingsong; Burke, John M.; Castellano, Daniel; Font, Albert; Ganju, Vinod; Hardy-Bessard, Anne-Claire; McDermott, Ray; Sautois, Brieuc; Spaeth, Dominique; Voog, Eric; Piulats, Josep M.; Pintus, Elias; Ryan, Charles J.; Merseburger, Axel S.; Daugaard, Gedske; Heidenreich, Axel; Fizazi, Karim; Loehry, Andrea; Despain, Darrin; Simmons, Andrew D.; Dowsonz, Melanie; Goy, Jowell; Watkinsz, Simon P.; Chowdhury, Simon
Combination of nivolumab with standard of care in the management of grade group 5 prostate cancer: Interim analysis of a phase II trial
CANCER RESEARCH
IF16.6
2023-04-141
PRE
Bryant, John Michael; Sandoval, Maria; Putney, Ryan; Caslini, Corrado; Awasthi, Shivanshu; Katende, Esther; Fink, Angelina; Naqvi, Syeda Mahrukh H.; Kim, Youngchul; Zhang, Jingsong; Park, Jong; Serna, Amparo; Pow-Sang, Julio; Poch, Michael; Li, Roger; Manley, Brandon; Naghavi, Arash; Torres-Roca, Javier; Grass, G. Daniel; Kim, Sungjune; Latifi, Kujtim; Hunt, Dylan; Johnstone, Peter A.; Dhillon, Jasreman; Jain, Rohit; Fernandez, Daniel; Yamoah, Kosj
Emergence of BRCA Reversion Mutations in Patients with Metastatic Castration-resistant Prostate Cancer After Treatment with Rucaparib
EUROPEAN UROLOGY
IF25.2
2023-03-0124
OA
Loehr, Andrea; Hussain, Arif; Patnaik, Akash; Bryce, Alan H.; Castellano, Daniel; Font, Albert; Shapiro, Jeremy; Zhang, Jingsong; Sautois, Brieuc; Vogelzang, Nicholas J.; Chatta, Gurkamal; Courtney, Kevin; Harzstark, Andrea; Ricci, Francesco; Despain, Darrin; Watkins, Simon; King, Charmin; Nguyen, Minh; Simmons, Andrew D.; Chowdhury, Simon; Abida, Wassim

研究方向

暂未获取到该数据
R
Robert A. Gatenby
H 指数:94论文数:807被引数:3.8万
J
Jasreman Dhillon
H 指数:30论文数:337被引数:2,908
P
Philippe E. Spiess
H 指数:60论文数:999被引数:1.7万
R
Roger Li
H 指数:0论文数:8被引数:68
A
Alexander R.A. Anderson
H 指数:67论文数:707被引数:1.7万
Y
Youngchul Kim
H 指数:34论文数:527被引数:3,770
S
Scott M. Gilbert
H 指数:37论文数:298被引数:4,626
W
Wade J. Sexton
H 指数:46论文数:405被引数:9,300
M
Michael Poch
H 指数:26论文数:240被引数:2,873
J
Julio M. Pow‐Sang
H 指数:53论文数:437被引数:1.2万